Get started
Work

MA11.08 IMpower010: Exploratory Analysis of Tumour Mutational Burden and Disease-Free Survival with Adjuvant Atezolizumab in NSCLC

Year: 2023
Type: conference-abstract
DOI: 10.1016/j.jtho.2023.09.193
Authors: E. Felip, M. Srivastava, M. Reck, H. Wakelee, N. Altorki, E. Vallieres, R. Liersch, S. Oizumi, H. Tanaka, J.T. Hamm, S. Novello, S. McCune, L. Molinero, V. McNally, S. Morris, M. Ballinger, H. Li, W. Zou, B.J. Nabet, E. Bennett, B.J. Gitlitz, C. Zhou
Institutions: Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, German Center for Lung Research, LungenClinic Grosshansdorf, Stanford Medicine, Stanford Cancer Institute, Stanford University, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Clemenshospital Münster, Sapporo National Hospital, Niigata Cancer Center Hospital, Ospedale San Luigi Gonzaga, University of Turin, Roche (United Kingdom), Roche (Switzerland), Shanghai Pulmonary Hospital
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4388045001
Cites:
Cited by: 7
Related to: 10